UBT251
UBT251 is a pharmaceutical drug with 6 clinical trials. Currently 4 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
2
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
4
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
UBT251 Injection Phase II Clinical Study (CKD)
Clinical Trials (6)
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
UBT251 Injection Phase II Clinical Study (CKD)
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6